three new ORAL drugs for multiple sclerosis...Ampyra, cladribine, and fingolimod

Please see updated information from the FDA concerning Ampyra and the risk of seizures

Patients will be asking about three new ORAL drugs for multiple sclerosis...Ampyra, cladribine, and fingolimod.

These will be the first oral drugs approved for treating MS.

Ampyra (Am-PEER-ah, dalfampridine) will be available soon through specialty pharmacies...and costs over $13,000 a year.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote